... | ... | ... | Active substance | Medicinal product name | Pharmaceutical form | Strength | ATC code | Max. price range (€ incl. VAT) | ||
---|---|---|---|---|---|---|---|---|---|---|
Not available (according to the information provided by wholesalers) | Prescription (Pr.) | Cabazitaxelum | Cabazitaxel Accord | Concentrate for solution for infusion | 20 mg/ml |
Not available (according to the information provided by wholesalers) Prescription (Pr.) |
L01CD04 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.) | Cabazitaxelum | Cabazitaxel Fresenius Kabi 20 mg/ml concentrate for solution for infusion | Concentrate for solution for infusion | 20 mg/ml |
Not available (according to the information provided by wholesalers) Prescription (Pr.) |
L01CD04 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.) | Cabazitaxelum | Cabazitaxel Stada 20 mg/ml concentrate for solution for infusion | Concentrate for solution for infusion | 20 mg/ml |
Not available (according to the information provided by wholesalers) Prescription (Pr.) |
L01CD04 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.) | Cabazitaxelum | Eleber 60 mg concentrate and solvent for solution for infusion | Concentrate and solvent for solution for infusion | 60 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.) |
L01CD04 — ANTINEOPLASTIC AGENTS | skatīt informāciju par zālēm un iepakojumiem | ||
Not available (according to the information provided by wholesalers) | Prescription (Pr.II stac.) | Cabazitaxelum | JEVTANA | Concentrate and solvent for solution for infusion | 60 mg |
Not available (according to the information provided by wholesalers) Prescription (Pr.II stac.) |
L01CD04 — ANTINEOPLASTIC AGENTS | € 5967.18 | skatīt informāciju par zālēm un iepakojumiem |